Physician profile
John Leech
NPI 1356334833
$9,201.80
in general payments reported to CMS, 2019-2025
47 companies · $1,699 in 2025
The $1,699 reported for 2025 was more than what 76% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,232 · 2020: $774 · 2021: $1,233 · 2022: $589 · 2023: $618 · 2024: $1,057 · 2025: $1,699.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,374.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,373.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neotract INC. | $1,974.67 | 2019-2020 | |
| Dendreon Pharmaceuticals LLC | $1,092.47 | 2019-2025 | Provenge |
| Teleflex LLC | $763.87 | 2020-2025 | Urolift, Barrigel |
| Janssen Biotech, INC. | $690.13 | 2019-2025 | Rybrevant, Carvykti, Erleada |
| Bayer Healthcare Pharmaceuticals INC. | $661.50 | 2019-2025 | |
| Medtronic, INC. | $395.21 | 2022-2023 | Interstim |
| Astellas Pharma US INC | $388.74 | 2019-2025 | Xtandi |
| Pfizer INC. | $337.46 | 2019-2025 | |
| Ferring Pharmaceuticals INC. | $322.11 | 2019-2025 | Adstiladrin |
| Bioprotect Medical, INC. | $321.35 | 2024-2025 | Bioprotect Balloon Implant System |
| Boston Scientific Corporation | $223.01 | 2019-2025 | Rezum Generator, Axonics, Lithovue |
| Urogen Pharma, INC. | $174.62 | 2021-2025 | |
| Sumitomo Pharma America, INC. | $167.23 | 2024-2025 | Gemtesa, Orgovyx |
| Abbvie INC. | $157.10 | 2021-2025 | |
| Antares Pharma, INC. | $148.82 | 2024-2025 | Xyosted, Tlando |
Show all 47 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Leech listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.